Sandbox: wdx causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 39: Line 39:
|-
|-
! rowspan="22" style="background: #DCDCDC; padding: 5px; text-align: center;" |Prerenal causes
! rowspan="22" style="background: #DCDCDC; padding: 5px; text-align: center;" |Prerenal causes
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alcohol poisoning]]<ref name="pmid15589492">{{cite journal |vauthors=Pletcher MJ, Maselli J, Gonzales R |title=Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey |journal=Am. J. Med. |volume=117 |issue=11 |pages=863–7 |date=December 2004 |pmid=15589492 |doi=10.1016/j.amjmed.2004.07.042 |url=}}</ref><ref name="pmid2927129">{{cite journal |vauthors=Cherpitel CJ |title=Breath analysis and self-reports as measures of alcohol-related emergency room admissions |journal=J. Stud. Alcohol |volume=50 |issue=2 |pages=155–61 |date=March 1989 |pmid=2927129 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alcohol poisoning]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
Line 52: Line 52:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]] (isopropyl [[alcohol]])
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]] (isopropyl [[alcohol]])
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Bicarbonate|HCO3]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Bicarbonate|HCO3]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thiamine]] must be given to prevent [[Wernicke's encephalopathy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thiamine]] must be given to prevent [[Wernicke's encephalopathy]]
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aspergillosis|'''Aspergillosis''']]<ref name="pmid11880955">{{cite journal |vauthors=Marr KA, Carter RA, Crippa F, Wald A, Corey L |title=Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients |journal=Clin. Infect. Dis. |volume=34 |issue=7 |pages=909–17 |date=April 2002 |pmid=11880955 |doi=10.1086/339202 |url=}}</ref><ref name="pmid16886149">{{cite journal |vauthors=Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP |title=Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey |journal=Clin. Infect. Dis. |volume=43 |issue=5 |pages=577–84 |date=September 2006 |pmid=16886149 |doi=10.1086/505870 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Aspergillosis|'''Aspergillosis''']]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 72: Line 72:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Allergy test]], ↑[[IgE]] (>1000 IU/dl), Direct visualization of [[Hyphae|fungal hyphae]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Allergy test]], ↑[[IgE]] (>1000 IU/dl), Direct visualization of [[Hyphae|fungal hyphae]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Pulmonary infiltrates, [[Mucus|Mucus plug]], Mass in the upper lobe surrounded by a crescent of air, Solitary or multiple cavities
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Pulmonary infiltrates, [[Mucus|Mucus plug]], Mass in the upper lobe surrounded by a crescent of air, Solitary or multiple cavities
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Halo sign, Wedge-shaped pulmonary [[infarction]], [[Granuloma]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Halo sign, Wedge-shaped pulmonary [[infarction]], [[Granuloma]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Polymerase chain reaction|Polymerase chain reaction (PCR)]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Polymerase chain reaction|Polymerase chain reaction (PCR)]]  
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cholera|'''Cholera''']]<ref name="pmid19842974">{{cite journal |vauthors=Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, Calderwood SB, Qadri F, Harris JB |title=Clinical outcomes in household contacts of patients with cholera in Bangladesh |journal=Clin. Infect. Dis. |volume=49 |issue=10 |pages=1473–9 |date=November 2009 |pmid=19842974 |pmc=2783773 |doi=10.1086/644779 |url=}}</ref><ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref><ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref><ref name="pmid21696312">{{cite journal |vauthors=Harris JB, Ivers LC, Ferraro MJ |title=Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea |journal=N. Engl. J. Med. |volume=364 |issue=25 |pages=2452–61 |date=June 2011 |pmid=21696312 |doi=10.1056/NEJMcpc1100927 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cholera|'''Cholera''']]<ref name="pmid4809112">{{cite journal |vauthors=Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB |title=Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum |journal=J. Infect. Dis. |volume=129 |issue=1 |pages=45–52 |date=January 1974 |pmid=4809112 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
Line 98: Line 98:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Ca]], ↑[[Mg]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Ca]], ↑[[Mg]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]], ↓[[Bicarbonate|HCO3]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]], ↓[[Bicarbonate|HCO3]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Stool PCR, Stool culture, Serotyping  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Stool PCR, Stool culture, Serotyping  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Congestive heart failure]] (CHF)<ref name="pmid17724259">{{cite journal |vauthors=Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA |title=Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure |journal=Circulation |volume=116 |issue=13 |pages=1482–7 |date=September 2007 |pmid=17724259 |doi=10.1161/CIRCULATIONAHA.107.696906 |url=}}</ref><ref name="pmid15687312">{{cite journal |vauthors=Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ |title=Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis |journal=JAMA |volume=293 |issue=5 |pages=572–80 |date=February 2005 |pmid=15687312 |doi=10.1001/jama.293.5.572 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Congestive heart failure]] (CHF)
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 121: Line 121:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Potassium|K]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Potassium|K]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]], ↓[[Bicarbonate|HCO3]],  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]], ↓[[Bicarbonate|HCO3]],  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[BNP]], ↑[[Troponin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[BNP]], ↑[[Troponin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiomegaly]], [[Pulmonary hypertension]], [[Pleural effusions]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiomegaly]], [[Pulmonary hypertension]], [[Pleural effusions]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulmonary edema]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulmonary edema]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Valvular heart disease]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Valvular heart disease]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Decreased [[ejection fraction]] in [[echocardiography]], Heart function and damage in nuclear imaging
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Decreased [[ejection fraction]] in [[echocardiography]], Heart function and damage in nuclear imaging
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dehydration]]<ref name="pmid15187057">{{cite journal |vauthors=Steiner MJ, DeWalt DA, Byerley JS |title=Is this child dehydrated? |journal=JAMA |volume=291 |issue=22 |pages=2746–54 |date=June 2004 |pmid=15187057 |doi=10.1001/jama.291.22.2746 |url=}}</ref><ref name="pmid9220501">{{cite journal |vauthors=Vega RM, Avner JR |title=A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children |journal=Pediatr Emerg Care |volume=13 |issue=3 |pages=179–82 |date=June 1997 |pmid=9220501 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dehydration]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
Line 141: Line 141:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Potassium|K]], ↓[[Chloride|Cl]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↑[[Potassium|K]], ↓[[Chloride|Cl]]
Line 147: Line 147:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]], ↓[[Bicarbonate|HCO3]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]], ↓[[Bicarbonate|HCO3]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hypoglycemia]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hypoglycemia]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diarrhea]] and/or [[vomiting]]<ref name="pmid2178747">{{cite journal |vauthors=Carpenter DO |title=Neural mechanisms of emesis |journal=Can. J. Physiol. Pharmacol. |volume=68 |issue=2 |pages=230–6 |date=February 1990 |pmid=2178747 |doi= |url=}}</ref><ref name="pmid22454468">{{cite journal |vauthors=Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, Brunett P, Bulens S, Beard RS, Dauphin LA, Slutsker L, Bopp C, Eberhard M, Hall A, Vinje J, Monroe SS, Glass RI |title=The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States |journal=J. Infect. Dis. |volume=205 |issue=9 |pages=1374–81 |date=May 2012 |pmid=22454468 |doi=10.1093/infdis/jis206 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diarrhea]] and/or [[vomiting]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
Line 165: Line 165:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]] with predominant [[neutrophilia]], ↑ [[ESR]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]] with predominant [[neutrophilia]], ↑ [[ESR]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Ketones]], Organic acids, [[Porphobilinogen]], [[Aminolevulinic acid]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Ketones]], Organic acids, [[Porphobilinogen]], [[Aminolevulinic acid]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Stool [[anion gap]], Stool pH < 5.5, Stool culture, Serotyping, Enzyme immunoassay ([[rotavirus]] or [[adenovirus]]), [[Liver function tests|LFT]], [[Amylase]], [[Lipase]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Stool [[anion gap]], Stool pH < 5.5, Stool culture, Serotyping, Enzyme immunoassay ([[rotavirus]] or [[adenovirus]]), [[Liver function tests|LFT]], [[Amylase]], [[Lipase]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Normal
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Normal
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drugs]]/[[Toxin|toxins]]<ref name="pmid1883120">{{cite journal |vauthors=Toto RD, Mitchell HC, Lee HC, Milam C, Pettinger WA |title=Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis |journal=Ann. Intern. Med. |volume=115 |issue=7 |pages=513–9 |date=October 1991 |pmid=1883120 |doi= |url=}}</ref><ref name="pmid4715199">{{cite journal |vauthors=Bismuth C, Gaultier M, Conso F, Efthymiou ML |title=Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications |journal=Clin. Toxicol. |volume=6 |issue=2 |pages=153–62 |date=1973 |pmid=4715199 |doi=10.3109/15563657308990513 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drugs]]/[[Toxin|toxins]]


| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
Line 188: Line 188:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]], ↑[[Creatine kinase|CK]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]], ↑[[Creatine kinase|CK]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Potassium|K]], ↓[[Magnesium|Mg]], ↓[[Ca]], ↓[[Phosphate|P]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Potassium|K]], ↓[[Magnesium|Mg]], ↓[[Ca]], ↓[[Phosphate|P]]
Line 196: Line 196:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Nephropathy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Nephropathy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Radioopaque substances, Ingested drug packets  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Radioopaque substances, Ingested drug packets  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Esophageal varices|'''Esophageal varices bleeding''']]<ref name="pmid6970703">{{cite journal |vauthors=Graham DY, Smith JL |title=The course of patients after variceal hemorrhage |journal=Gastroenterology |volume=80 |issue=4 |pages=800–9 |date=April 1981 |pmid=6970703 |doi= |url=}}</ref><ref name="pmid20638742">{{cite journal |vauthors=de Franchis R |title=Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension |journal=J. Hepatol. |volume=53 |issue=4 |pages=762–8 |date=October 2010 |pmid=20638742 |doi=10.1016/j.jhep.2010.06.004 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Esophageal varices|'''Esophageal varices bleeding''']]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 213: Line 213:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Normocytic normochromic anemia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Normocytic normochromic anemia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Velocity and direction of [[portal]] flow
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Velocity and direction of [[portal]] flow
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Abnormal opacities  outside of[[esophageal]] wall, Posterior [[mediastinal]] or intraparenchymal mass, Dilated [[azygous vein]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Abnormal opacities  outside of[[esophageal]] wall, Posterior [[mediastinal]] or intraparenchymal mass, Dilated [[azygous vein]]
Line 224: Line 224:
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Heart disease]]<ref name="pmid2030718">{{cite journal |vauthors=LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH |title=Smoking and mortality among older men and women in three communities |journal=N. Engl. J. Med. |volume=324 |issue=23 |pages=1619–25 |date=June 1991 |pmid=2030718 |doi=10.1056/NEJM199106063242303 |url=}}</ref><ref name="pmid19581259">{{cite journal |vauthors=Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD |title=Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP |journal=Pediatrics |volume=124 |issue=2 |pages=823–36 |date=August 2009 |pmid=19581259 |doi=10.1542/peds.2009-1397 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Heart disease]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 236: Line 236:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[ESR]] and [[CRP]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[ESR]] and [[CRP]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Throat culture]], Rapid streptococcal antigen test, Hyperoxia test, [[Pulse oximetry]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Throat culture]], Rapid streptococcal antigen test, Hyperoxia test, [[Pulse oximetry]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiomegaly]], [[Dextrocardia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiomegaly]], [[Dextrocardia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Ventricular dysfunction]], Left and right ventricular [[hypertrophy]], Valvular disease in [[echocardiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Ventricular dysfunction]], Left and right ventricular [[hypertrophy]], Valvular disease in [[echocardiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhage]]<ref name="pmid21098468">{{cite journal |vauthors=Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH |title=Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface |journal=Circulation |volume=122 |issue=20 |pages=2068–77 |date=November 2010 |pmid=21098468 |doi=10.1161/CIRCULATIONAHA.110.936773 |url=}}</ref><ref name="pmid3487361">{{cite journal |vauthors=Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y |title=Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease |journal=Blood |volume=68 |issue=1 |pages=58–61 |date=July 1986 |pmid=3487361 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhage]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 260: Line 260:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Sodium|Na]], ↑[[Chloride|Cl]], ↓[[Ca]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Sodium|Na]], ↑[[Chloride|Cl]], ↓[[Ca]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Metabolic acidosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Metabolic acidosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Peritoneal cavity fluid in [[FAST]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Peritoneal cavity fluid in [[FAST]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral opacities in the lung field, [[Hemothorax]], Hemoperitoneum, Ruptured [[abdominal aortic aneurysm]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral opacities in the lung field, [[Hemothorax]], Hemoperitoneum, Ruptured [[abdominal aortic aneurysm]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Intrathoracic, intra-abdominal, and retroperitoneal [[bleeding]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Intrathoracic, intra-abdominal, and retroperitoneal [[bleeding]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Source of [[bleeding]] in the upper GI in [[Esophagogastroduodenoscopy|EGD]], [[Angiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Source of [[bleeding]] in the upper GI in [[Esophagogastroduodenoscopy|EGD]], [[Angiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolysis]]<ref name="pmid3814817">{{cite journal |vauthors=Liesveld JL, Rowe JM, Lichtman MA |title=Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases |journal=Blood |volume=69 |issue=3 |pages=820–6 |date=March 1987 |pmid=3814817 |doi= |url=}}</ref><ref name="pmid7365971">{{cite journal |vauthors=Marchand A, Galen RS, Van Lente F |title=The predictive value of serum haptoglobin in hemolytic disease |journal=JAMA |volume=243 |issue=19 |pages=1909–11 |date=May 1980 |pmid=7365971 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemolysis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 281: Line 281:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thrombocytopenia|Thrombocytopenia,]] [[Microcytic anemia|Microcytic hypochromic anemia]], ↑RDW, ↑[[Reticulocyte|Retic]] count
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Thrombocytopenia|Thrombocytopenia,]] [[Microcytic anemia|Microcytic hypochromic anemia]], ↑RDW, ↑[[Reticulocyte|Retic]] count
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[LDH]], ↓[[Haptoglobin]], ↑Unconjugated [[bilirubin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[LDH]], ↓[[Haptoglobin]], ↑Unconjugated [[bilirubin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hepatomegaly]],[[Splenomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hepatomegaly]],[[Splenomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
Line 320: Line 320:
! align="center" style="background:#4479BA; color: #FFFFFF;" |Comments
! align="center" style="background:#4479BA; color: #FFFFFF;" |Comments
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hepatorenal syndrome]]<ref name="pmid19776409">{{cite journal |vauthors=Ginès P, Schrier RW |title=Renal failure in cirrhosis |journal=N. Engl. J. Med. |volume=361 |issue=13 |pages=1279–90 |date=September 2009 |pmid=19776409 |doi=10.1056/NEJMra0809139 |url=}}</ref><ref name="pmid8550036">{{cite journal |vauthors=Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J |title=Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club |journal=Hepatology |volume=23 |issue=1 |pages=164–76 |date=January 1996 |pmid=8550036 |doi=10.1002/hep.510230122 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hepatorenal syndrome]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 334: Line 334:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Proteinuria]],  [[Sodium|Na]] < 10 mEq/L, [[Urine osmolality]] > [[plasma osmolality]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Proteinuria]],  [[Sodium|Na]] < 10 mEq/L, [[Urine osmolality]] > [[plasma osmolality]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Alpha fetoprotein|Alpha feto-protein]], [[Cryoglobulinemia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Alpha fetoprotein|Alpha feto-protein]], [[Cryoglobulinemia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Exclude [[hydronephrosis]] and intrinsic renal disease
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Exclude [[hydronephrosis]] and intrinsic renal disease
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Right ventricular preload, ventricular filling pressures, and cardiac function in [[echocardiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Right ventricular preload, ventricular filling pressures, and cardiac function in [[echocardiography]]
| -
| -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cardiomyopathy|Ischemic cardiomyopathy]]<ref name="pmid16567565">{{cite journal |vauthors=Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB |title=Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention |journal=Circulation |volume=113 |issue=14 |pages=1807–16 |date=April 2006 |pmid=16567565 |doi=10.1161/CIRCULATIONAHA.106.174287 |url=}}</ref><ref name="pmid15689345">{{cite journal |vauthors=Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G |title=Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology |journal=Eur. Heart J. |volume=26 |issue=5 |pages=516–24 |date=March 2005 |pmid=15689345 |doi=10.1093/eurheartj/ehi108 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cardiomyopathy|Ischemic cardiomyopathy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 356: Line 356:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↓[[Potassium|K]], ↓[[Magnesium|Mg]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Sodium|Na]], ↓[[Potassium|K]], ↓[[Magnesium|Mg]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Troponin]], [[Creatine kinase]], [[Creatine kinase]] - MB, [[Brain natriuretic peptide|BNP]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Troponin]], [[Creatine kinase]], [[Creatine kinase]] - MB, [[Brain natriuretic peptide|BNP]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Abnormal cardiac silhouette
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Abnormal cardiac silhouette
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Biventricular volume, Wall motion abnormality, Myocardial perfusion, [[Hypertrophic cardiomyopathy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Biventricular volume, Wall motion abnormality, Myocardial perfusion, [[Hypertrophic cardiomyopathy]]
Line 366: Line 366:
| -
| -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Liver cirrhosis]]<ref name="pmid24076364">{{cite journal |vauthors=Ge PS, Runyon BA |title=The changing role of beta-blocker therapy in patients with cirrhosis |journal=J. Hepatol. |volume=60 |issue=3 |pages=643–53 |date=March 2014 |pmid=24076364 |doi=10.1016/j.jhep.2013.09.016 |url=}}</ref><ref name="pmid3533689">{{cite journal |vauthors=Becker CD, Scheidegger J, Marincek B |title=Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography |journal=Gastrointest Radiol |volume=11 |issue=4 |pages=305–11 |date=1986 |pmid=3533689 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Liver cirrhosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 376: Line 376:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]], [[Aspartate aminotransferase]] to [[platelet]] ratio, FibroTest/FibroSure, Hepascore, FibroSpectatio
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]], [[Aspartate aminotransferase]] to [[platelet]] ratio, FibroTest/FibroSure, Hepascore, FibroSpectatio
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Portal blood flow velocity, [[Hepatic artery]] enlargement, Multifocal  lesions or masses, Hepatic contour, [[Ascites]], [[Splenomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Portal blood flow velocity, [[Hepatic artery]] enlargement, Multifocal  lesions or masses, Hepatic contour, [[Ascites]], [[Splenomegaly]]
Line 389: Line 389:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Irreversible and a transplant is usually needed
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Irreversible and a transplant is usually needed
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignant hypertension]]<ref name="pmid23102030">{{cite journal |vauthors=Johnson W, Nguyen ML, Patel R |title=Hypertension crisis in the emergency department |journal=Cardiol Clin |volume=30 |issue=4 |pages=533–43 |date=November 2012 |pmid=23102030 |doi=10.1016/j.ccl.2012.07.011 |url=}}</ref><ref name="pmid16627047">{{cite journal |vauthors=Elliott WJ |title=Clinical features in the management of selected hypertensive emergencies |journal=Prog Cardiovasc Dis |volume=48 |issue=5 |pages=316–25 |date=2006 |pmid=16627047 |doi=10.1016/j.pcad.2006.02.004 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Malignant hypertension]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 405: Line 405:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Acidosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Acidosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiac enzymes]], Urinary [[catecholamines]], [[TSH]], ↑[[Renin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiac enzymes]], Urinary [[catecholamines]], [[TSH]], ↑[[Renin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Cardiomegaly, [[Pulmonary edema]], Rib notching, [[Aortic coarctation]], Mediastinal widening, [[Aortic dissection]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Cardiomegaly, [[Pulmonary edema]], Rib notching, [[Aortic coarctation]], Mediastinal widening, [[Aortic dissection]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Left atrial enlargement and left ventricular [[hypertrophy|hypertrophy in]] [[echocardiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Left atrial enlargement and left ventricular [[hypertrophy|hypertrophy in]] [[echocardiography]]
| -
| -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myocarditis]]<ref name="pmid39746742">{{cite journal |vauthors=Dec GW, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA |title=Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome |journal=N. Engl. J. Med. |volume=312 |issue=14 |pages=885–90 |date=April 1985 |pmid=3974674 |doi=10.1056/NEJM198504043121404 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myocarditis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 423: Line 423:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]] ([[eosinophilia]]),↑[[ESR]] and [[CRP]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]] ([[eosinophilia]]),↑[[ESR]] and [[CRP]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiac enzymes]], Viral antibodies
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Cardiac enzymes]], Viral antibodies
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Inflammatory [[edema]], Degree of scarring
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Inflammatory [[edema]], Degree of scarring
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Endomyocardial biopsy]], [[Echocardiography]], [[Scintigraphy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Endomyocardial biopsy]], [[Echocardiography]], [[Scintigraphy]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Peritonitis]]<ref name="pmid97980132">{{cite journal |vauthors=Such J, Runyon BA |title=Spontaneous bacterial peritonitis |journal=Clin. Infect. Dis. |volume=27 |issue=4 |pages=669–74; quiz 675–6 |date=October 1998 |pmid=9798013 |doi= |url=}}</ref><ref name="pmid22106722">{{cite journal |vauthors=Runyon BA |title=Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis |journal=Hepatology |volume=12 |issue=4 Pt 1 |pages=710–5 |date=October 1990 |pmid=2210672 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Peritonitis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 446: Line 446:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Leukocytosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Ascitic fluid [[neutrophil]] count > 500 cells/µL
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Ascitic fluid [[neutrophil]] count > 500 cells/µL
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polycythemia]]<ref name="pmid90251652">{{cite journal |vauthors=Gregg XT, Prchal JT |title=Erythropoietin receptor mutations and human disease |journal=Semin. Hematol. |volume=34 |issue=1 |pages=70–6 |date=January 1997 |pmid=9025165 |doi= |url=}}</ref><ref name="pmid92925432">{{cite journal |vauthors=Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT |title=Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias |journal=Blood |volume=90 |issue=5 |pages=2057–61 |date=September 1997 |pmid=9292543 |doi= |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polycythemia]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 470: Line 470:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[RBC]], ↑[[Hematocrit|HCT]], ↑[[Hemoglobin|HGB]], [[Thrombocytosis]], [[Leukocytosis]], ↑[[PT]] and [[aPTT]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[RBC]], ↑[[Hematocrit|HCT]], ↑[[Hemoglobin|HGB]], [[Thrombocytosis]], [[Leukocytosis]], ↑[[PT]] and [[aPTT]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Erythropoietin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Erythropoietin]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hyperuricemia]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Hyperuricemia]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Splenomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Splenomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Phlebotomy]] is the usual treatment
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Phlebotomy]] is the usual treatment
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Respiratory distress syndrome]]<ref name="pmid265428772">{{cite journal |vauthors=Hooper SB, Te Pas AB, Kitchen MJ |title=Respiratory transition in the newborn: a three-phase process |journal=Arch. Dis. Child. Fetal Neonatal Ed. |volume=101 |issue=3 |pages=F266–71 |date=May 2016 |pmid=26542877 |doi=10.1136/archdischild-2013-305704 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Respiratory distress syndrome]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
Line 491: Line 491:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Metabolic acidosis|Metabolic]] and [[Metabolic acidosis|respiratory acidosis]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Metabolic acidosis|Metabolic]] and [[Metabolic acidosis|respiratory acidosis]]  
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulse oximetry]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pulse oximetry]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral, diffuse, reticular granular or ground-glass appearance +/- [[Cardiomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Bilateral, diffuse, reticular granular or ground-glass appearance +/- [[Cardiomegaly]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Patent ductus arteriosus]] [[hypertrophy|in]] [[echocardiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Patent ductus arteriosus]] [[hypertrophy|in]] [[echocardiography]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Shock]]<ref name="pmid24171518">{{cite journal |vauthors=Vincent JL, De Backer D |title=Circulatory shock |journal=N. Engl. J. Med. |volume=369 |issue=18 |pages=1726–34 |date=October 2013 |pmid=24171518 |doi=10.1056/NEJMra1208943 |url=}}</ref>
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Shock]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |<nowiki>+/-</nowiki>
Line 516: Line 516:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Hematocrit|HCT]], ↑[[PT]] and [[aPTT]], [[Eosinophilia]], [[Leukocytosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Hematocrit|HCT]], ↑[[PT]] and [[aPTT]], [[Eosinophilia]], [[Leukocytosis]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↓[[Glomerular filtration rate|GFR]], ↑[[Blood urea nitrogen|BUN]], ↑[[Cr]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |↑[[Lactate]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]],  ↑[[BNP]], ↑[[Troponin]], [[D-dimer]], [[Fibrinogen]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Liver function tests|LFT]],  ↑[[BNP]], ↑[[Troponin]], [[D-dimer]], [[Fibrinogen]]
Line 523: Line 523:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pneumonia]], [[Pneumothorax]], [[Pulmonary edema]], Widened [[mediastinum]], Free air under the [[diaphragm]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |[[Pneumonia]], [[Pneumothorax]], [[Pulmonary edema]], Widened [[mediastinum]], Free air under the [[diaphragm]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Traumatic brain injury, [[Stroke]], Spinal injury, [[Pneumonia]], [[Pneumothorax]], Ruptured [[aneurysm]], [[Aortic dissection]], [[Pulmonary embolism]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Traumatic brain injury, [[Stroke]], Spinal injury, [[Pneumonia]], [[Pneumothorax]], Ruptured [[aneurysm]], [[Aortic dissection]], [[Pulmonary embolism]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Not applicable
| style="background: #F5F5F5; padding: 5px; text-align: center;" |NA
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
| style="background: #F5F5F5; padding: 5px; text-align: center;" | -
|-
|-
|}
|}
<references />

Revision as of 15:13, 23 July 2018

Differential Diagnosis

Abbreviations: ABG = Arterial blood gases, BUN = Blood urea nitrogen, CBC = Complete blood count, CT = Computed tomography, CRP = C - reactive protein, ECG = Electrocardiogram, ESR = Erythrocyte sedimentation rate, IVP = Intravenous pyelography, KFT = Kidney function test, GI = Gastrointestinal, GFR = Glomerular filtration rate, MRI = Magnetic resonance imaging, PT = Prothrombin time

Etiology Clinical manifestations Paraclinical findings Comments
Symptoms and signs Lab findings Imaging
Fatigue/

Lethargy

Thirst Dizziness/

Confusion

Muscle weakness/

cramp

Somatic/

visceral pain

Vomiting Diarrhea Tachypnea Edema Blood indices Renal Funtion test Electrolytes Urine analysis ABG Other Ultrasound X-ray CT MRI Other
Prerenal causes Alcohol poisoning + + +/- - +/- + +/- - - ↑PT ↑BUN, ↑Cr (isopropyl alcohol) ↓Na NA ↓HCO3 LFT NA NA NA NA - Thiamine must be given to prevent Wernicke's encephalopathy
Aspergillosis +/- - - - - - - +/- - NA NA NA NA NA Allergy test, ↑IgE (>1000 IU/dl), Direct visualization of fungal hyphae NA Pulmonary infiltrates, Mucus plug, Mass in the upper lobe surrounded by a crescent of air, Solitary or multiple cavities Halo sign, Wedge-shaped pulmonary infarction, Granuloma NA - Polymerase chain reaction (PCR)
Cholera[1] +/- + - - - +/- + - - Leukocytosis, ↑HCT ↑BUN, ↑Cr ↓Na, ↑Ca, ↑Mg NA ↑Lactate, ↓HCO3 Stool PCR, Stool culture, Serotyping NA NA NA NA - -
Congestive heart failure (CHF) + - - - - - + - + Anemia, Leukocytosis ↑BUN, ↑Cr ↓Na, ↑K NA ↑Lactate, ↓HCO3, ↑BNP, ↑Troponin Cardiomegaly, Pulmonary hypertension, Pleural effusions Pulmonary edema NA Valvular heart disease Decreased ejection fraction in echocardiography, Heart function and damage in nuclear imaging -
Dehydration + + - +/- - +/- +/- - - NA ↑BUN, ↑Cr ↓Na, ↑K, ↓Cl Ketones and glucose, ↑Urine specific gravity ↑Lactate, ↓HCO3 Hypoglycemia NA NA NA NA - -
Diarrhea and/or vomiting +/- +/- - - - + + - - Leukocytosis with predominant neutrophilia, ↑ ESR NA NA Ketones, Organic acids, Porphobilinogen, Aminolevulinic acid NA Stool anion gap, Stool pH < 5.5, Stool culture, Serotyping, Enzyme immunoassay (rotavirus or adenovirus), LFT, Amylase, Lipase Normal NA NA NA - -
Drugs/toxins +/- +/- +/- +/- +/- +/- +/- +/- +/- NA ↑BUN, ↑Cr, ↑CK ↑K, ↓Mg, ↓Ca, ↓P Ingested drug, Glucose, Aminoacid, Phosphate, Ketone, Hyaline cast, RBC ↑Lactate, Metabolic acidosis Toxicology, Rapid immunoassay Nephropathy Radioopaque substances, Ingested drug packets NA NA - -
Esophageal varices bleeding +/- - - - +/- - - - - Normocytic normochromic anemia ↑BUN, ↑Cr NA NA NA NA Velocity and direction of portal flow Abnormal opacities outside ofesophageal wall, Posterior mediastinal or intraparenchymal mass, Dilated azygous vein Entire portal venous system Portrays esophageal varices as flow voids Portal hypertension and esophageal varices in positron emission tomography, Flexible endoscope, Barium swallow of snake-like filling defects -
Heart disease +/- - - - - - - +/- +/- ↑ESR and CRP ↑BUN, ↑Cr NA NA NA Throat culture, Rapid streptococcal antigen test, Hyperoxia test, Pulse oximetry NA Cardiomegaly, Dextrocardia NA NA Ventricular dysfunction, Left and right ventricular hypertrophy, Valvular disease in echocardiography -
Hemorrhage - - - - - - - - - Normocytic normochromic anemia, ↑PT, ↑PTT ↑BUN, ↑Cr ↑Na, ↑Cl, ↓Ca NA Metabolic acidosis NA Peritoneal cavity fluid in FAST Bilateral opacities in the lung field, Hemothorax, Hemoperitoneum, Ruptured abdominal aortic aneurysm Intrathoracic, intra-abdominal, and retroperitoneal bleeding NA Source of bleeding in the upper GI in EGD, Angiography -
Hemolysis +/- - - - - - - - - Thrombocytopenia, Microcytic hypochromic anemia, ↑RDW, ↑Retic count NA NA NA NA ↑LDH, ↓Haptoglobin, ↑Unconjugated bilirubin Hepatomegaly,Splenomegaly NA NA NA - -
Etiology Fatigue/

Lethargy

Thirst Dizziness/

Confusion

Muscle weakness/

cramp

Somatic/

visceral pain

Vomiting Diarrhea Tachypnea Edema Blood indices Renal Funtion test Electrolytes Urine analysis ABG Other Ultrasound X-ray CT MRI Other Comments
Hepatorenal syndrome +/- - - - +/- +/- - - +/- Leukocytosis, ↑PT ↓GFR, ↑BUN, ↑Cr ↓Na Proteinuria, Na < 10 mEq/L, Urine osmolality > plasma osmolality NA Alpha feto-protein, Cryoglobulinemia Exclude hydronephrosis and intrinsic renal disease NA NA NA Right ventricular preload, ventricular filling pressures, and cardiac function in echocardiography -
Ischemic cardiomyopathy +/- - - - - - - +/- +/- Anemia ↑Cr ↓Na, ↓K, ↓Mg NA NA Troponin, Creatine kinase, Creatine kinase - MB, BNP NA Abnormal cardiac silhouette Biventricular volume, Wall motion abnormality, Myocardial perfusion, Hypertrophic cardiomyopathy Mid-wall fibrosis in MRI Ejection fraction ≤35%, Pulmonary embolism, Right ventricular dilation or pericardial effusion with tamponade in echocardiography -
Liver cirrhosis +/- - +/- +/- +/- - - - +/- NA NA NA NA NA LFT, Aspartate aminotransferase to platelet ratio, FibroTest/FibroSure, Hepascore, FibroSpectatio Portal blood flow velocity, Hepatic artery enlargement, Multifocal lesions or masses, Hepatic contour, Ascites, Splenomegaly Bowel perforation, Gynecomastia, Azygos vein enlargement, Pleural effusion Morphologic changes in the liver, Collaterals and shunts, Hyperattenuating nodule of hepatocellular carcinoma, Portal vein thrombosis Vacular patency, Tumor invasion, Portal vein thrombosis, Steatosis Hepatic function and portal hypertension in nuclear imaging, Hepatic perfusion and the development of shunts and tumors in angiography Irreversible and a transplant is usually needed
Malignant hypertension +/- - + - - +/- - +/- +/- Microangiopathic hemolytic anemia ↑BUN, ↑Cr ↑Na, ↑K, ↑P Proteinuria, Microscopic hematuria Acidosis Cardiac enzymes, Urinary catecholamines, TSH, ↑Renin NA Cardiomegaly, Pulmonary edema, Rib notching, Aortic coarctation, Mediastinal widening, Aortic dissection NA NA Left atrial enlargement and left ventricular hypertrophy in echocardiography -
Myocarditis +/- - - - +/- - - +/- - Leukocytosis (eosinophilia),↑ESR and CRP NA NA NA NA Cardiac enzymes, Viral antibodies NA NA NA Inflammatory edema, Degree of scarring Endomyocardial biopsy, Echocardiography, Scintigraphy NA
Peritonitis +/- - +/- - +/- +/- +/- - - Leukocytosis NA NA NA NA Ascitic fluid neutrophil count > 500 cells/µL NA NA NA NA - -
Polycythemia +/- - - - - - - +/- - ↑RBC, ↑HCT, ↑HGB, Thrombocytosis, Leukocytosis, ↑PT and aPTT ↓Erythropoietin NA NA NA Hyperuricemia Splenomegaly NA NA NA - Phlebotomy is the usual treatment
Respiratory distress syndrome + - +/- - - - - + - NA NA NA NA Metabolic and respiratory acidosis Pulse oximetry NA Bilateral, diffuse, reticular granular or ground-glass appearance +/- Cardiomegaly NA NA Patent ductus arteriosus in echocardiography -
Shock +/- +/- +/- +/- +/- +/- - +/- - ↑HCT, ↑PT and aPTT, Eosinophilia, Leukocytosis ↓GFR, ↑BUN, ↑Cr NA NA ↑Lactate LFT, ↑BNP, ↑Troponin, D-dimer, Fibrinogen Pulmonary embolism, Pericardial effusion, Cardiac tamponade, Pneumothorax, Thoracic or abdominal aortic aneurysm in RUSH (Rapid Ultrasound for Shock and Hypotension) Pneumonia, Pneumothorax, Pulmonary edema, Widened mediastinum, Free air under the diaphragm Traumatic brain injury, Stroke, Spinal injury, Pneumonia, Pneumothorax, Ruptured aneurysm, Aortic dissection, Pulmonary embolism NA - -
  1. ↑ Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB (January 1974). "Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum". J. Infect. Dis. 129 (1): 45–52. PMID 4809112.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:_wdx_causes&oldid=1484495"